Intuitive Surgical, Inc. Tax Benefit from Stock Options Exercised (Deprecated 2012-01-31)
Intuitive Surgical, Inc. (ISRG) reported Tax Benefit from Stock Options Exercised (Deprecated 2012-01-31) of $20.20 million for the 3-month period ending 2012-03-31, per its 10-Q filed 2012-04-19.
Discontinued › Expense Statement › Income Tax
us-gaap:TaxBenefitFromStockOptionsExercised · last filed 2012-04-19
- Intuitive Surgical, Inc. tax benefit from stock options exercised (deprecated 2012-01-31) for the quarter ending 2012-03-31 was $20.20M, a 74.14% increase year-over-year.
- Intuitive Surgical, Inc. tax benefit from stock options exercised (deprecated 2012-01-31) for the quarter ending 2011-12-31 was $12.40M, a 47.62% increase year-over-year.
- Intuitive Surgical, Inc. tax benefit from stock options exercised (deprecated 2012-01-31) for the quarter ending 2011-09-30 was $15.10M, a 71.59% increase year-over-year.
- Intuitive Surgical, Inc. tax benefit from stock options exercised (deprecated 2012-01-31) for the quarter ending 2011-06-30 was $9.50M, a 29.10% decline year-over-year.
- Intuitive Surgical, Inc. tax benefit from stock options exercised (deprecated 2012-01-31) for fiscal 2011 was $48.60M, a 16.06% decline from fiscal 2010.
- Intuitive Surgical, Inc. tax benefit from stock options exercised (deprecated 2012-01-31) for fiscal 2010 was $57.90M, a 145.34% increase from fiscal 2009.
- Intuitive Surgical, Inc. tax benefit from stock options exercised (deprecated 2012-01-31) for fiscal 2009 was $23.60M, a 57.78% decline from fiscal 2008.
- Intuitive Surgical, Inc. tax benefit from stock options exercised (deprecated 2012-01-31) for fiscal 2008 was $55.90M, a 14.51% decline from fiscal 2007.
| Period end | Tax Benefit from Stock Options Exercised (Deprecated 2012-01-31) 3 month | Tax Benefit from Stock Options Exercised (Deprecated 2012-01-31) 6 month | Tax Benefit from Stock Options Exercised (Deprecated 2012-01-31) 9 month | Tax Benefit from Stock Options Exercised (Deprecated 2012-01-31) 12 month | Tax Benefit from Stock Options Exercised (Deprecated 2012-01-31) 12 month as first filed |
|---|---|---|---|---|---|
| 2012-03-31 | $20.20M 10-Q · filed 2012-04-19 | $32.60M derived: sum of 2 quarters · filed 2012-04-19 | $47.70M derived: sum of 3 quarters · filed 2012-04-19 | $57.20M derived: sum of 4 quarters · filed 2012-04-19 | |
| 2011-12-31 | $12.40M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-06 | $27.50M derived: sum of 2 quarters · filed 2012-02-06 | $37.00M derived: sum of 3 quarters · filed 2012-02-06 | $48.60M 10-K · filed 2012-02-06 | |
| 2011-09-30 | $15.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-19 | $24.60M derived: sum of 2 quarters · filed 2011-10-19 | $36.20M 10-Q · filed 2011-10-19 | $44.60M derived: sum of 4 quarters · filed 2012-04-19 | |
| 2011-06-30 | $9.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-07-20 | $21.10M 10-Q · filed 2011-07-20 | $29.50M derived: sum of 3 quarters · filed 2012-04-19 | $38.30M derived: sum of 4 quarters · filed 2012-04-19 | |
| 2011-03-31 | $11.60M 10-Q · filed 2012-04-19 | $20.00M derived: sum of 2 quarters · filed 2012-04-19 | $28.80M derived: sum of 3 quarters · filed 2012-04-19 | $42.20M derived: sum of 4 quarters · filed 2012-04-19 | |
| 2010-12-31 | $8.40M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-06 | $17.20M derived: sum of 2 quarters · filed 2012-02-06 | $30.60M derived: sum of 3 quarters · filed 2012-02-06 | $57.90M 10-K · filed 2012-02-06 | |
| 2010-09-30 | $8.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-19 | $22.20M derived: sum of 2 quarters · filed 2011-10-19 | $49.50M 10-Q · filed 2011-10-19 | $64.40M derived: sum of 4 quarters · filed 2012-02-06 | |
| 2010-06-30 | $13.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-07-20 | $40.70M 10-Q · filed 2011-07-20 | $55.60M derived: sum of 3 quarters · filed 2012-02-06 | $63.60M derived: sum of 4 quarters · filed 2012-02-06 | |
| 2010-03-31 | $27.30M 10-Q · filed 2011-04-20 | $42.20M derived: sum of 2 quarters · filed 2012-02-06 | $50.20M derived: sum of 3 quarters · filed 2012-02-06 | $50.90M derived: sum of 4 quarters · filed 2012-02-06 | |
| 2009-12-31 | $14.90M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-06 | $22.90M derived: sum of 2 quarters · filed 2012-02-06 | $23.60M derived: sum of 3 quarters · filed 2012-02-06 | $23.60M 10-K · filed 2012-02-06 | $23.64M 10-K · filed 2010-01-29 |
| 2009-09-30 | $8.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-10-20 | $8.70M derived: sum of 2 quarters · filed 2010-10-20 | $8.70M 10-Q · filed 2010-10-20 | ||
| 2009-06-30 | $700.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2010-07-23 | $700.00K 10-Q · filed 2010-07-23 | |||
| 2009-03-31 | $0.00 10-Q · filed 2010-04-20 | ||||
| 2008-12-31 | $55.90M 10-K · filed 2011-02-01 | $55.93M 10-K · filed 2010-01-29 | |||
| 2007-12-31 | $65.39M 10-K · filed 2010-01-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Edwards Lifesciences Corp (EW) | United States | $49.409B | 51.96 |
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |